How to Talk to Your Doctor About GLP-1 Medications: Questions to Ask and What to Expect

For informational purposes only — not medical advice. Treatment decisions should be made with a licensed clinician.

Introduction

Starting a conversation with your doctor about GLP-1-based medications can feel uncomfortable. Maybe you worry about being judged. Maybe you're not sure if you even qualify. Maybe you've tried to lose weight before and don't want to rehash that history all over again.

But asking your doctor about these medications is not asking for a shortcut. It is asking for medical care. Obesity is a complex, chronic disease influenced by genetics, hormones, metabolism, and environment. Prescription medications may be one part of evidence-based care for some patients — depending on the specific medication and your health history, these treatments may help with weight management, blood sugar control, and other obesity-related health goals.

The problem isn't that these medications exist. The problem is that most patients walk into appointments unprepared, leave without the conversation they needed, and go home no closer to a solution.

This guide changes that.

By the time you finish reading, you'll know:

• How to prepare before your appointment
• Exactly how to bring up these medications without feeling awkward
• The specific questions to ask (and which ones most people forget)
• What to do if your doctor says yes — and what to do if your doctor says no
• Word-for-word scripts you can use or adapt
• When telehealth may be a legitimate alternative path

Whether you're managing Type 2 diabetes, struggling with chronic weight gain, or simply trying to understand your options, this guide will help you walk into that appointment with confidence.

What Are GLP-1-Based Medications?

Before your appointment, it helps to understand what you're asking about. You don't need a medical degree — but understanding the basics can help you have a clearer, more productive conversation with your doctor.

A Plain-Language Definition

GLP-1 stands for glucagon-like peptide-1. GLP-1-based medications are a class of prescription drugs that work with hormones your body naturally releases in response to eating. These hormones signal the pancreas to release insulin, slow the movement of food through your stomach, and communicate with the brain that you've had enough to eat.

In short: these medications work with your body's own biology to reduce hunger, improve blood sugar regulation, and — in many patients — support meaningful weight loss.

One important note: tirzepatide (Mounjaro/Zepbound) is a dual GIP and GLP-1 receptor agonist, meaning it activates two different hormone receptors, not just one. When this article refers to "GLP-1-based medications," it includes tirzepatide under that broader umbrella, but tirzepatide's mechanism is distinct from single-receptor GLP-1 agonists like semaglutide and liraglutide.

The Medications in This Category

The medications most likely to come up in your conversation include:

• Wegovy (semaglutide) injection — FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related condition; also approved to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.
• Wegovy (semaglutide) tablets — FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related condition; also approved to reduce cardiovascular risk in adults with established cardiovascular disease and either obesity or overweight.
• Ozempic (semaglutide) — FDA-approved for adults with Type 2 diabetes; also approved to reduce cardiovascular risk in adults with Type 2 diabetes and established cardiovascular disease, and to reduce the risk of kidney disease progression in adults with Type 2 diabetes and chronic kidney disease.
• Rybelsus (semaglutide tablets) — FDA-approved for adults with Type 2 diabetes; also approved to reduce the risk of major adverse cardiovascular events in adults with Type 2 diabetes at high cardiovascular risk.
• Zepbound (tirzepatide) — FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related condition; also approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
• Mounjaro (tirzepatide) — FDA-approved to improve blood sugar control in adults and pediatric patients age 10 and older with Type 2 diabetes.
• Saxenda (liraglutide) — FDA-approved for chronic weight management in adults and certain adolescents.
• Victoza (liraglutide) — FDA-approved for Type 2 diabetes and to reduce cardiovascular risk in adults with Type 2 diabetes and established cardiovascular disease.

A Note on Compounded Versions

Some pharmacies and telehealth companies market compounded semaglutide or tirzepatide. Compounded versions are not FDA-approved. The FDA has warned about dosing errors, adverse events, products made with salt forms that differ from the approved active ingredient, and illegal online sales. The FDA also announced that the tirzepatide injection shortage was resolved in December 2024, and the semaglutide injection shortage was resolved in February 2025. Patients should be especially careful with compounded products and should use only legitimate, state-licensed pharmacies under the supervision of a licensed clinician.

Why a Doctor's Guidance Matters

These medications are not one-size-fits-all. The right choice depends on your existing diagnoses, other medications you take, your insurance coverage, your dosing preferences, your weight history, and several other clinical factors. Some people are not candidates due to specific contraindications. Proper dosing, titration, and monitoring can make a meaningful difference in both safety and outcomes.

This is a medical conversation, and your doctor is your most important resource in it.

Are You a Candidate? Know Before You Go

One of the most common reasons patients don't bring up GLP-1-based medications is that they don't know whether they qualify. Understanding the general eligibility criteria before your appointment removes that uncertainty.

FDA-Approved Criteria for Weight Management

For FDA-approved chronic weight-management use, adults generally qualify if they have:

• A BMI of 30 or higher, or
• A BMI of 27 or higher combined with at least one weight-related condition, such as high blood pressure, dyslipidemia (high cholesterol), Type 2 diabetes, obstructive sleep apnea, or cardiovascular disease

Eligibility still depends on the specific medication and your medical history. Some patients also ask about these medications in the context of conditions such as PCOS or fatty liver disease — whether they're appropriate in those cases depends on the specific diagnosis and the clinician's judgment.

For GLP-1-based medications approved for Type 2 diabetes (Ozempic, Mounjaro, Victoza, Rybelsus), your doctor may prescribe them primarily for blood sugar management, with weight loss as a secondary benefit.

Conditions That May Affect Your Candidacy

Not everyone is a good candidate, and some risks depend on the exact medication. Formal contraindications for most GLP-1-based medications include:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• A previous serious allergic reaction to the medication

The following are not automatic disqualifiers, but are important warnings and precautions that your doctor will factor into the decision:

• Pregnancy or plans to become pregnant
• Severe gastroparesis or other severe gastrointestinal disease
• A history of pancreatitis, gallbladder disease, diabetic retinopathy, or kidney disease — these may change how your clinician evaluates risk, monitoring, and dehydration management

Being upfront about all of these factors is essential to your safety — and to getting a complete evaluation.

How to Prepare Before Your Appointment

The quality of your appointment often comes down to how prepared you are. Here's what to gather before you go.

Know Your Numbers

Bring — or at least know — the following:

• Your current weight and height (to calculate your BMI if your doctor doesn't have recent records)
• Recent lab results, if available: A1C, fasting glucose, lipid panel, kidney function (GFR/creatinine), liver enzymes
• Blood pressure readings from recent visits

If you don't have recent labs, your appointment may include ordering them before any medication can be started — which is completely normal.

Compile Your Medical History

Think through and be ready to discuss:

• All current medications and supplements (some have interactions)
• Any history of thyroid conditions, pancreatitis, gallstones, or kidney disease
• Prior weight-loss attempts: what you tried, how long, and what happened
• Family history of thyroid cancer or endocrine disorders

Write Down Your Health Goals

Be specific. "I want to lose weight" is fine as a starting point, but your doctor will have a more productive conversation with you if you can say:

• "I want to reduce my A1C from 7.4 to under 7.0."
• "I've been trying to lose 40 pounds for three years. Nothing has worked long-term."
• "My blood pressure is high, and I want to reduce my cardiovascular risk."

Goal clarity also helps your doctor assess which medication — if any — is best suited to your situation.

Understand Your Insurance Situation

These medications can be expensive without insurance coverage, and prior authorization is common — especially for weight-management indications. Before your appointment:

• Call your insurance to ask whether these medications are on your formulary
• Ask specifically about weight-management formulations (Wegovy, Zepbound) versus diabetes formulations (Ozempic, Mounjaro) — coverage criteria differ significantly
• Ask whether prior authorization is required
• Ask if step therapy (proving you've tried other methods first) applies

Bringing this information lets your doctor know what they're working with when it comes to prescribing.

Write Down Your Questions

Don't rely on memory when you're nervous and sitting in an exam room. Print or write down your questions. (A complete list is in the next section.)

How to Start the Conversation

This is where most people get stuck. Here are straightforward ways to bring up GLP-1-based medications without it feeling awkward.

Keep It Direct

You don't need a lengthy preamble. A clear, calm opening works best:

• "I'd like to talk about whether GLP-1-based medications might be appropriate for me."
• "I've been reading about prescription options for weight management and I'd like your input on whether I'm a candidate."
• "Can we discuss my options for treating my weight and whether medication might play a role?"

These openers signal that you've done some research, you have a specific question, and you're ready for a clear medical discussion about treatment options.

If You've Already Tried Everything

"I've made significant changes to my diet and exercise habits over the past few years, but I'm still not seeing sustainable results. I'd like to talk about whether there's a medical component to what I'm experiencing and whether GLP-1 therapy could help."

This framing communicates that you're asking for the next clinical step — not a shortcut.

If You're Managing Diabetes or Blood Sugar

"I want to get my blood sugar under better control and reduce my long-term risk. I'd like to discuss whether a GLP-1-based medication could be part of my treatment plan."

If You're Feeling Nervous or Judged

It's okay to name it: "I'm a little uncomfortable bringing this up, but I want to have an honest conversation about my weight and what my medical options are."

Most physicians will meet that openness with respect. If they don't, that's important information — a telehealth provider or obesity medicine specialist may be a better fit.

Frame It as a Partnership

You're not demanding a prescription. You're asking for medical input. That distinction matters. A collaborative tone — "I'd like your guidance on this" versus "I want this medication" — often leads to a better outcome.

Questions to Ask Your Doctor

This is the section to print out and bring with you. Organized by category, these questions will give you the most useful information.

About Eligibility

• Am I a candidate for GLP-1-based therapy based on my current health profile?
• Do I meet the medical or insurance criteria for one of the approved weight-management medications (Wegovy or Zepbound)?
• Are there any conditions in my history that would make this unsafe?
• Do I need any labs or tests before we can move forward?
• Are there reasons you'd recommend waiting or trying something else first?

About Medication Options

• Which medication do you recommend for my situation, and why that one specifically?
• What is the difference between Wegovy and Zepbound for weight loss?
• What is the difference between semaglutide and tirzepatide?
• Is an injectable or oral option more appropriate for me?
• Now that Wegovy is available in tablet form, would that be relevant for my situation?
• Is liraglutide (Saxenda) still a reasonable option, or do the newer medications have better outcomes for my situation?
• What dose would we start with, and how does titration work?

About Cost and Insurance

• Will my insurance cover this medication? Is prior authorization required?
• What is the process if my insurance denies coverage?
• Are there manufacturer savings programs I should know about? (Novo Nordisk offers NovoCare assistance for Wegovy; Eli Lilly offers savings programs for Zepbound)
• What would this medication cost if insurance won't cover it?
• What do you think about compounded semaglutide or tirzepatide given FDA's recent guidance on these products?

About Side Effects and Safety

• What are the most common side effects, and how should I manage them?
• What symptoms should prompt me to call your office promptly?
• What symptoms should send me to urgent care or the ER?
• Are there interactions with my current medications I should know about?
• How does this medication affect blood sugar if I'm also on metformin or insulin?
• What happens if I need to stop taking it?

About What to Expect

• What results are realistic for someone with my profile in three, six, and twelve months?
• How long before I notice changes in appetite?
• Is weight loss the only benefit I should expect, or are there other health improvements based on your assessment?
• What typically happens to weight if someone stops the medication long-term?

About Monitoring and Follow-Up

• How often will we meet to check my progress?
• What labs will you order while I'm on the medication?
• What would cause you to adjust the dose or stop treatment?
• How will we define success together?

Important Topics to Discuss Honestly

Your doctor can only help you based on what you tell them. The following areas are where patients most commonly leave out information — sometimes out of embarrassment, sometimes because they don't realize it's relevant.

Your Full Medical History

Be complete about:

• Any history of pancreatitis (even a single episode)
• Gallbladder issues or gallstones
• Thyroid nodules or family history of thyroid cancer
• Kidney or liver disease
• Gastroparesis or chronic GI disorders
• A history of eating disorders (these medications affect appetite significantly — this warrants discussion)
• Depression, anxiety, or psychiatric medication use

Your Current Habits

Doctors ask about lifestyle not to judge you, but because it affects how treatment is designed. Be straightforward about:

• What you actually eat (not the idealized version)
• Alcohol use (alcohol can worsen GI side effects and affect blood sugar)
• Sleep and stress levels
• Physical activity — or lack of it
• Any supplements or over-the-counter medications, including weight-loss products

Your Realistic Expectations

Be honest with yourself — and your doctor — about:

• How quickly you're hoping to see results
• Whether you're open to long-term treatment versus a short-term course
• What "success" actually means to you
• Whether you're prepared for the lifestyle changes that tend to improve results

Your Barriers

If cost, injection concerns, forgetfulness, or access to follow-up care is a concern, say so. These barriers have real solutions — manufacturer savings programs, oral semaglutide options where appropriate, different dosing schedules, reminder systems, or referral options — but only if your doctor knows about them.

What Your Doctor May Ask You

Be ready for these questions. Complete, honest answers will help your doctor give you better guidance.

Health Background

• What are your current diagnoses?
• Has your weight changed significantly in the past year?
• Do you have a family history of obesity, Type 2 diabetes, or thyroid disease?
• Have you taken any weight-loss medications before? What happened?

Lifestyle Questions

• Walk me through a typical day of eating.
• How active are you? What does exercise look like for you right now?
• How much alcohol do you drink weekly?
• How is your sleep?

Motivation and Readiness

• Why are you interested in this now?
• What have you already tried?
• Are you prepared for regular follow-up and potential long-term treatment?

These aren't trick questions — they're your doctor trying to build an accurate clinical picture.

Word-for-Word Scripts for Your Appointment

If you're still not sure what to say, use one of these as a starting point. Adapt them to your situation and tone.

The Straightforward Ask

"I've been doing some research and I'd like to talk about whether I'm a candidate for a GLP-1-based medication — either for weight management or blood sugar control. Can we go through my health history and see if it makes sense for me?"

For Weight Management

"I've been struggling with my weight for years. I've tried diet and exercise, and while I've made progress, I'm not able to sustain results long-term. I'd like to understand whether the biology behind that has a medical solution — and whether GLP-1 therapy is something worth considering for me."

For Type 2 Diabetes

"I want to get my A1C lower and reduce my long-term cardiovascular risk. I've read that some of these medications have benefits in both areas. Can we talk about whether one might be appropriate as part of my diabetes management plan?"

If You're Nervous About Being Dismissed

"I want to be direct with you: I'm not looking for a quick fix. I've taken my health seriously, and I'd like to have a real clinical conversation about whether medication can play a role in my treatment. Can we talk through the options?"

If You've Already Been Refused Once

"We discussed this before and you had concerns — I understand that. I want to revisit it because [your situation has changed / you've done more research / your weight has continued to increase]. Is there anything that would make me a stronger candidate, or would you recommend a referral to an obesity medicine specialist?"

If Your Doctor Says No

A "no" isn't necessarily the end of the conversation. Understanding why it happened changes what you do next.

Why a Doctor Might Say No

A doctor may say no because of a safety concern, because more labs or history are needed first, because another option may fit your situation better, or because they prefer to refer you to an obesity medicine specialist or endocrinologist for medication selection and long-term follow-up. If you don't feel you received a full clinical evaluation, it is reasonable to ask for a second opinion.

How to Respond

Ask these follow-up questions:

• "Can you help me understand specifically why I'm not a candidate?"
• "Is this a permanent medical concern, or something we could revisit?"
• "Would you be willing to refer me to an obesity medicine specialist?"
• "Is there anything I could bring to a future appointment that would change your assessment?"

Your Other Options

Obesity medicine specialists are physicians with board certification in obesity medicine. They typically have more focused experience with GLP-1-based therapy and weight management pharmacology. Ask your PCP for a referral, or find a board-certified specialist through the Obesity Medicine Association's provider directory.

Telehealth providers can be a reasonable option when care is provided by a clinician who is licensed to practice in the state where you're located, can take an appropriate history and order testing when indicated, provides ongoing follow-up, and uses legitimate state-licensed pharmacies. Be especially cautious with programs that market compounded semaglutide or tirzepatide as if they are equivalent to FDA-approved products.

Navigating Insurance and Prior Authorization

Cost is one of the biggest barriers to GLP-1 access — and insurance coverage for these medications, especially for weight management rather than diabetes, remains inconsistent.

How Prior Authorization Works

Prior authorization (PA) means your insurance company requires approval before it will cover a medication. For GLP-1 weight-management medications, PA requirements often include:

• Documentation of your BMI and qualifying conditions
• Evidence that you've tried and failed other weight-loss interventions (step therapy)
• A letter of medical necessity from your prescribing physician

Your doctor's office will typically handle the PA paperwork, but you can advocate for yourself by:

• Asking your doctor to document your full clinical picture — not just weight, but every relevant comorbidity
• Keeping records of previous weight-loss attempts, including dates, methods, and results
• Following up with your insurer to track the status of your PA request

If Your Insurance Denies Coverage

A denial is not final. Your options include:

1. Appeal the denial — Ask your insurer for the specific reason for denial, then work with your doctor to submit a formal appeal with supporting documentation.
2. Request a peer-to-peer review — Your physician can request a direct conversation with the insurance company's medical reviewer. This process frequently reverses denials.
3. Apply for a medical necessity exception — Some plans have a process for approving non-formulary medications when medically necessary.
4. Manufacturer savings programs — Novo Nordisk and Eli Lilly both offer savings cards and patient assistance programs that can significantly reduce out-of-pocket costs for eligible patients.

A Note on Compounded GLP-1 Medications

Compounded semaglutide and tirzepatide are not FDA-approved. The FDA has issued warnings about dosing errors, adverse events, products made with salt forms that differ from the approved active ingredient, and illegal online sales. The FDA has also stated that the tirzepatide injection shortage was resolved in December 2024 and the semaglutide injection shortage was resolved in February 2025 — which affects when compounded copies of these products may be lawfully prescribed.

If cost or access is a concern, ask your clinician directly: Is the product being considered FDA-approved or compounded? Which pharmacy would dispense it? Why is that option being recommended in your specific case? Use only legitimate, state-licensed pharmacies.

Telehealth as a Legitimate Alternative Path

If your PCP is unwilling to engage, if you don't have a primary care doctor, or if cost and convenience are significant concerns, telehealth can be a medically legitimate option — when the right standards are in place.

What a Telehealth GLP-1 Consultation Looks Like

The process typically works like this:

1. You complete a health intake form online, including your current weight, health conditions, medications, and goals.
2. A licensed physician or nurse practitioner reviews your intake.
3. You may have a synchronous video visit, or the provider may review your case asynchronously.
4. If eligible, you receive a prescription sent to a licensed pharmacy.
5. Ongoing care typically involves check-ins, dose adjustments, and access to support resources.

Questions to Vet a Telehealth Provider

Not all telehealth providers offering GLP-1 medications operate to the same clinical standard. Before you sign up, confirm:

• Is the prescriber licensed or otherwise authorized to practice in your state?
• Does the provider take a thorough medical history and order labs when indicated?
• What is the ongoing monitoring protocol?
• Is the prescription for an FDA-approved medication, or a compounded product? If compounded, why?
• What is the total monthly cost, including medication?
• What is the cancellation policy?

If Your Doctor Says Yes: What Comes Next

Getting the prescription is the beginning, not the end. Here's what to expect.

Before You Fill the Prescription

Make sure you understand:

• Which medication was prescribed and why
• Starting dose and titration schedule
• How to use the medication (if injectable — your doctor's office or pharmacist can walk you through technique; if oral, take it as directed on the label)
• What side effects to expect in the first few weeks and how to manage them
• What symptoms warrant calling the office
• When your first follow-up appointment is scheduled

The First Weeks: The Titration Phase

Many semaglutide-, tirzepatide-, and liraglutide-based regimens start at a low dose and are increased over time to improve tolerability. The exact schedule depends on the specific drug and formulation — follow the prescribing instructions for the product you are using. During the early weeks, common experiences include:

• Nausea — the most frequently reported side effect, especially around dose increases. For most people it improves within a few days.
• Fatigue — can occur early in treatment.
• Constipation or diarrhea — GI side effects vary significantly by individual.
• Appetite changes — may be subtle at first, becoming more noticeable as the dose increases.

GI side effects are common early in treatment and often become more manageable over time. Let your clinician know if symptoms are severe, persistent, or making it hard to keep down food or fluids.

Lifestyle Factors That Support Results

These medications are significantly more effective when combined with lifestyle changes. In your daily routine:

• Ask your clinician or a registered dietitian how to meet your protein, hydration, and activity needs while losing weight — especially if you are eating less than usual or have another medical condition that affects your nutritional needs.
• Resistance training helps preserve lean muscle mass during weight loss.
• Sleep quality affects hunger hormones and how the body responds to treatment.
• Staying hydrated is especially important for managing GI side effects and avoiding dehydration-related complications.

Red Flags to Report Promptly

Contact your clinician promptly if you experience:

• Severe or persistent abdominal pain
• Persistent vomiting or signs of dehydration
• Symptoms of low blood sugar (shakiness, sweating, confusion) — particularly if you also use insulin or a sulfonylurea
• Allergic-reaction symptoms such as swelling, rash, or trouble breathing
• Vision changes, especially if you have diabetes

What to Expect at Follow-Up

Follow-up commonly includes weight, symptom review, dose tolerance, and — when relevant — blood glucose or A1C, eye symptoms in patients with diabetes, and kidney function if dehydration or other concerns arise. The exact monitoring plan depends on the medication, your diagnosis, and your medical history.

Special Situations: Tailoring the Conversation

If You Have Type 2 Diabetes

If you're currently on metformin, insulin, or a sulfonylurea, make sure your doctor discusses how those medications will be managed alongside GLP-1 therapy — the risk of hypoglycemia can increase when these drugs are combined. Some semaglutide products now have FDA-approved cardiovascular or kidney-related indications in specific populations, so the best option may depend on whether you also have established cardiovascular disease or chronic kidney disease. Ask your doctor which, if any, of these indications apply to your situation.

If You Have PCOS

PCOS often overlaps with insulin resistance and weight-management challenges. If you have PCOS, ask your clinician whether medication is appropriate for you and how your fertility goals or pregnancy plans should factor into the decision.

If You've Had Bariatric Surgery

This is a more individualized discussion. Bring the type of surgery you had, when you had it, and any complications or nutrition issues — your clinician will need that information to advise you appropriately.

If You Want to Switch Medications

If you're already on a GLP-1-based medication and want to discuss switching — for example, from semaglutide to tirzepatide — bring your current dose, duration of use, results so far, and any side effects. Your doctor will assess whether switching is clinically appropriate and how to transition safely.

If You're Considering Stopping

Weight regain can happen after stopping weight-management medication, which is one reason it is important to discuss a long-term plan with your clinician before making changes. Ask about a structured tapering or maintenance approach rather than stopping abruptly.

Common Mistakes to Avoid

Asking for a specific medication without giving your full health picture. Your doctor will give you a better assessment if you frame it as "I want to discuss my options" rather than asking for a brand name. Give them the complete context.

Hiding relevant medical history. Pancreatitis, thyroid nodules, a history of eating disorders — these matter clinically. Omitting them doesn't protect you; it prevents your doctor from protecting you.

Expecting immediate results. Many patients don't see significant weight loss in the first four to eight weeks. The titration phase is about tolerability and adjustment, not the scale.

Ignoring persistent GI side effects. Mild nausea is common. Persistent vomiting, severe pain, or an inability to keep food or fluids down are not — report them.

Assuming insurance is handled. Prior authorization is not automatic. Follow up with both your doctor's office and your insurance company.

Treating medication as a standalone solution. GLP-1-based medications work best as part of a broader treatment approach. Nutrition, movement, sleep, and stress management all interact with your results.

Skipping follow-up. Ongoing monitoring is not optional — it's how your doctor catches problems early, adjusts your dose, and confirms treatment is working safely.

Printable Doctor's Visit Prep Sheet

Bring this to your appointment.

Frequently Asked Questions

How do I ask my doctor for GLP-1-based medications?

Be direct and clinical: "I'd like to talk about whether a GLP-1-based medication is appropriate for my health situation." You're asking for medical guidance — come prepared with your health history and goals, and let the conversation go from there.

Will my doctor think I'm asking for a shortcut?

Most clinicians will recognize that a prepared, informed patient asking about prescription treatment for a chronic condition is engaging with their healthcare appropriately. If you feel persistently dismissed without a full clinical evaluation, asking for a second opinion or a referral to an obesity medicine specialist is reasonable.

Do I need to have diabetes to ask about these medications?

No. Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management in patients without diabetes who meet BMI criteria.

What if my doctor has never prescribed a GLP-1 for weight loss?

Ask whether they're comfortable prescribing, and if not, request a referral to an obesity medicine specialist. Telehealth providers that specialize in weight management are also an option when the clinical standards described earlier are met.

What if my insurance won't cover it?

Start with a prior authorization appeal. If that fails, ask your doctor about manufacturer patient assistance programs (Novo Nordisk and Eli Lilly both offer them). Ask your clinician about all available options, including whether cost-sharing programs are available for the specific medication being considered.

Are GLP-1-based medications safe long-term?

Longer-term safety data exist for some of these medications, but safety and benefit depend on the specific product, why it is being prescribed, and the patient's medical history. Some semaglutide products have FDA-approved cardiovascular indications in specific populations, but that does not mean every product or every patient carries the same risk-benefit profile. Ongoing follow-up with a licensed clinician is a core part of long-term use.

Is it safe to get a GLP-1 prescription from a telehealth provider?

Telehealth may be appropriate when the clinician is licensed or authorized in the state where you are located, can perform an appropriate medical evaluation, orders testing when needed, provides follow-up, and uses legitimate state-licensed pharmacies. Be especially cautious with programs selling compounded products as if they are equivalent to FDA-approved medications.

How do I know if a compounded GLP-1 is legitimate?

Because the FDA has raised concerns about dosing errors, salt form differences, and illegal online sales involving compounded GLP-1 products, the most important steps are to confirm the prescribing clinician is licensed in your state, ask specifically which pharmacy is dispensing the product and whether it is state-licensed, and understand why the compounded version is being recommended instead of an FDA-approved product. Use only legitimate, state-licensed pharmacies.

Am I a candidate if I'm only slightly overweight?

FDA-approved weight-management use generally starts at a BMI of 30 or higher, or BMI of 27 or higher plus a qualifying weight-related condition. Off-label prescribing exists, but patients should not assume they qualify based on a medication's popularity. The eligibility criteria exist for clinical reasons.

Conclusion

The conversation you have with your doctor about GLP-1-based medications is a medical one. These medications can be appropriate for some people and not appropriate for others — which is why a thorough discussion of your diagnosis, goals, risks, cost, and follow-up matters.

Walking in prepared — with your health history, current medications, and questions written down — can help you make a safer, more informed decision with your clinician.

If your doctor engages with you seriously, follow the plan. If you don't feel you received a complete evaluation, you have options: a referral to an obesity medicine specialist, a second opinion, and in some cases a telehealth provider who specializes in this area. The path to care isn't always direct, but knowing your options means you're never left without one.

Medical Sources

• FDA prescribing information: Wegovy (semaglutide injection and tablets), Ozempic (semaglutide), Rybelsus (semaglutide tablets), Zepbound (tirzepatide), Mounjaro (tirzepatide), Saxenda (liraglutide), Victoza (liraglutide)
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Prescription Medications to Treat Overweight & Obesity
• FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
• FDA: Press Announcement — Zepbound Approval for Obstructive Sleep Apnea
• Telehealth.HHS.gov: Licensure guidance for telehealth care
• Obesity Medicine Association: Find an Obesity Medicine Specialist
• CDC: About Obesity